Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products

DOI Web Site Web Site 1 Citations

Journal

Current Opinion in Biotechnology

Current Opinion in Biotechnology 78 102798-, 2022-12

Elsevier BV

Citations (1)*help

See more

Details 詳細情報について

CRID

1360580235926170240
DOI

10.1016/j.copbio.2022.102798
ISSN

09581669
Web Site

https://api.elsevier.com/content/article/PII:S095816692200132X?httpAccept=text/xml

https://api.elsevier.com/content/article/PII:S095816692200132X?httpAccept=text/plain
Data Source
- Crossref

Export

Report a problem

Back to top